Startups

Senior Director, Clinical Operations

Vir · San Francisco, California, United States · On-site

← All jobs
About Vir

Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond. Backed by SoftBank VF.

About the role

Vir Biotechnology is seeking an experienced Senior Director of Clinical Operations to provide portfolio-level strategic and operational leadership for multiple complex global oncology programs. This individual will be accountable for translating clinical development strategy into executable operational plans, delivering studies against timelines, budgets, quality standards, and decision-critical milestones, and proactively identifying and resolving risks that could affect program objectives. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Bachelor’s degree in life sciences or a related field and 15+ years of clinical development experience in the biotechnology or pharmaceutical industry
  • Significant experience overseeing complex global oncology clinical trials, with deep expertise in early-phase oncology development
  • Demonstrated experience leading first-in-human and early-development oncology trials, including dose-escalation, backfill, expansion, signal-seeking, and dose-optimization studies
  • Experience supporting development of novel oncology modalities, such as T-cell engagers, bispecific antibodies, immuno-oncology therapies, cell therapies, cytokine-based therapies, or related platforms
  • Strong understanding of clinical trial design and execution, including operational considerations in oncology studies
  • Extensive knowledge of FDA, EMA, ICH GCP, and other global regulatory requirements
More about this role

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN ® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.

Vir Biotechnology has exclusive rights to the universal PRO-XTEN ® masking platform for oncology and infectious disease. PRO-XTEN ® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.

We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.

Vir Biotechnology is seeking an experienced Senior Director of Clinical Operations to provide portfolio-level strategic and operational leadership for multiple complex global oncology programs. This individual will be accountable for translating clinical development strategy into executable...

Read the full posting on Vir's site ↗

Development

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.